Alluvi BPC-157 & TB-500 Blend 40mg | Dual-Peptide Laboratory Research Formulation

£100.00

Alluvi BPC-157 & TB-500 (40mg total) combines two well-documented investigational peptides into a single, high-purity research formulation. Engineered for comparative cell biology and regenerative signaling research, this co-formulation allows researchers to evaluate cellular migration, angiogenic signaling, and tissue matrix repair pathways in controlled in-vitro models. Supplied strictly for laboratory R&D and analytical investigation.

Alluvi BPC-157 & TB-500 40mg provides a balanced dual-peptide research system designed to facilitate the simultaneous evaluation of complementary cytoprotective and actin-regulating mechanisms. Rather than sourcing individual compounds separately, this research formulation offers a standardized baseline for investigating cellular cross-talk and tissue repair kinetics in a single assay setup:

  • BPC-157 (Body Protection Compound-157): A 15-amino acid pentadecapeptide investigated for its role in nitric oxide (NO) pathway regulation, VEGFR2 activation, cellular migration, and early-phase extracellular matrix remodeling.

  • TB-500 (Thymosin Beta-4 Fragment): A synthetic derivative of the naturally occurring actin-sequestering protein Thymosin $\beta_4$, studied extensively for actin polymerization dynamics, cell motility, angiogenesis, and anti-inflammatory signaling cascades.

By pairing these distinct molecular profiles, researchers can analyze the additive or synergistic effects of dual-pathway peptide mechanisms under controlled laboratory conditions.

Product Specifications

Parameter Specification
Product Name Alluvi BPC-157 & TB-500
Manufacturer Alluvi Healthcare
Total Stated Strength 40mg aggregate peptide content
Active Sequence Compounds BPC-157 Pentadecapeptide / TB-500 Acetylated Fragment
Format Lyophilized powder / Analytical solution
Application Grade In-vitro laboratory experimentation / Analytical R&D

Core Laboratory Research Applications

  • Comparative modeling of cellular motility, fibroblast recruitment, and tissue migration

  • In-vitro angiogenesis, vascular endothelial growth factor (VEGF) expression, and nitric oxide signaling

  • Cytoskeletal remodeling and G-actin / F-actin regulation studies

  • Extracellular matrix (ECM) synthesis, collagen deposition, and wound repair pathways

  • Peptide stability, co-solubility, and dual-compound degradation profiling

Storage & Handling Protocol

  • Store refrigerated at 2°C to 8°C for short-term bench use, or frozen at -20°C for long-term dry powder storage.

  • Shield the formulation from continuous UV light, ambient moisture, and excessive thermal exposure.

  • Once reconstituted with a suitable laboratory solvent, keep refrigerated at 2°C to 8°C and avoid repeated freeze-thaw cycles.

  • Record the batch and lot numbers alongside experimental records to ensure trace integrity.

Packaging & Dispatch

  • Shipped under monitored cold-chain conditions to protect peptide bonds from degradation during transit.

  • Dispatched in discreet, tamper-evident outer packaging.

  • Continuously cold-stored at regulated temperatures prior to shipment processing.

Research Use Only (RUO) Notice

Laboratory Notice: Alluvi BPC-157 & TB-500 40mg is supplied exclusively for non-clinical laboratory research, in-vitro testing, and analytical development. It is not an approved pharmaceutical, cosmetic, or food supplement. This product is strictly prohibited for human consumption, veterinary use, or therapeutic administration.

Tablets

20

Reviews

There are no reviews yet.

Be the first to review “Alluvi BPC-157 & TB-500 Blend 40mg | Dual-Peptide Laboratory Research Formulation”
Scroll to Top